Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Filings indexed 968 across all filing types
Latest filing 2020-08-19 Interim / Quarterly Rep…
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
ArcticZymes Technologies Q2 2020 Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q2 REPORT 2020' and contains comprehensive financial statements, operational reviews, and management commentary for the second quarter of the fiscal year. It provides detailed financial tables (Sales, EBITDA, EBIT, Cash flow) comparing Q2 2020 to Q2 2019. As it is a substantive quarterly financial report rather than a brief announcement or a full annual report, it is classified as an Interim/Quarterly Report. Q2 2020
2020-08-19 English
ArcticZymes Technologies Q2 2020 Report
Earnings Release Classification · 98% confidence The document is titled "ArcticZymes Technologies Q2 2020 Results" and provides key financial highlights (sales, EBITDA, gross profit) for the second quarter of 2020, along with commentary from the CEO. This structure—a summary of period-specific financial performance released shortly after the period ends—is characteristic of an Earnings Release (ER). Although it mentions a presentation will follow, the core content provided here is the initial announcement of the results, not the presentation itself (IP) or the full, comprehensive report (IR). It is not a 10-K (Annual Report) because it covers Q2, not the full year. It is not an Interim Report (IR) because it is a high-level summary announcement, typical of an ER, rather than the comprehensive filing that would accompany an IR. The document length (5102 chars) is substantial but focuses on highlights and commentary, fitting the ER definition. Q2 2020
2020-08-19 English
ArcticZymes Technologies Q2 2020 Report
Earnings Release Classification · 100% confidence The document is explicitly titled "ArcticZymes Technologies Q2 2020 Report" and contains detailed financial highlights (sales, EBITDA, gross profit) for the second quarter, along with commentary from the CEO. This structure strongly indicates a comprehensive financial report for a period shorter than a year. This aligns perfectly with the definition of an Interim / Quarterly Report (Code: IR). Although it mentions the results, report, and presentation will be available elsewhere, the content provided *is* the substance of the results announcement, making IR more appropriate than RPA or ER, as it contains substantial detail typical of an IR filing, not just highlights (ER) or an announcement of publication (RPA). Q2 2020
2020-08-19 English
ArcticZymes Technologies Q2 2020 Presentation
Investor Presentation Classification · 100% confidence The document is a slide deck titled 'Q2 2020' for ArcticZymes Technologies. It contains an agenda, highlights, segment-specific updates (ArcticZymes and BetaGlucans), detailed financial performance tables (Sales, EBITDA, Cash Flow), and an outlook section. It is clearly a presentation used to communicate financial results and business strategy to investors, fitting the definition of an Investor Presentation. Q2 2020
2020-08-19 English
ArcticZymes Technologies Q2 2020 Presentation
Report Publication Announcement Classification · 99% confidence The document is titled 'ArcticZymes Technologies Q2 2020 Presentation' and explicitly mentions presenting an 'interim report for the second quarter and first 6 months of 2020'. The text states, 'Please find the presentation attached.' Given the very short length (434 chars) and the nature of announcing an attached presentation related to interim financial results, this strongly suggests the document itself is the presentation material being shared, rather than the full interim report (IR) or the announcement of the report's publication (RPA). An Investor Presentation (IP) is the most fitting category for a company presentation accompanying interim results.
2020-08-19 English
ArcticZymes Technologies ASA: Invitation to presentation of Q2 2020 results
Report Publication Announcement Classification · 98% confidence The document is titled 'ArcticZymes Technologies ASA: Invitation to presentation of Q2 2020 results'. It explicitly states that the company will present its Q2 2020 report on a specific date and time via webcast/conference call. It provides details on how to join the presentation and notes that the actual Q2 2020 report will be available on their website and news service from 07:00 a.m. on the presentation day. Since this document is an invitation and announcement about the upcoming release and presentation of results, rather than the full results document itself (like an ER or IR), it fits best under Report Publication Announcement (RPA). The document length is short (1528 chars), supporting the 'announcement' classification over the full report.
2020-08-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.